Angiodynamics (ANGO) Income from Non-Controlling Interests (2014)
Angiodynamics' (ANGO) quarterly Income from Non-Controlling Interests came in at $57000.0 in Q1 2014.
Powered by 
Analysis
Angiodynamics (ANGO) Income from Non-Controlling Interests (2014) Analysis & Trends
Angiodynamics (ANGO) has reported Income from Non-Controlling Interests for 1 consecutive years, with $57000.0 the latest figure, recorded in Q1 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.00 Bn | 175.40 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.82 Bn | 122.60 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 116.94 Bn | 108.12 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 104.40 Bn | 100.92 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.93 Bn | 63.39 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.67 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn | - |
| 9 | Steris | 20.67 Bn | 20.19 Bn | 684.20 Mn | 900,000.00 |
| 10 | Angiodynamics | 626.63 Mn | 572.76 Mn | 46.77 Mn | - |